Status:
UNKNOWN
Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing
Lead Sponsor:
Data Collection Analysis Business Management
Collaborating Sponsors:
PAS Research Services
Conditions:
Colon Cancer
Endometrial Cancer
Eligibility:
All Genders
18-64 years
Brief Summary
Increase surveillance for LYNCH Syndrome
Detailed Description
The purpose of this minimal risk, observational survey is to increase surveillance for Lynch Syndrome (hereditary non-polyposis colon cancer), Colorectal, and Endometrial cancer, also to determine tar...
Eligibility Criteria
Inclusion
- Must be a Medical Practitioner
- Medical Doctor (MD)
- Doctor of Osteopathic (DO)
- Physician Assistant (PA)
- Advanced Practice Registered Nurse (APRN)
- Nurse Practitioner (NP)
- Must have a current standard operating procedure that includes obtaining/reviewing medical history and family medical history.
Exclusion
- Government-funded insurance data cannot be included in the study.
Key Trial Info
Start Date :
October 17 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03322176
Start Date
October 17 2017
End Date
November 1 2020
Last Update
January 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DCABM
Land O' Lakes, Florida, United States, 33558